Earningsreport

Q1/2025 3/31/2025 EPS -0.060 ZacksConsensus -0.060 ActVsEst 0.000 - In-Line

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com